110899 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Avulavirus, e.g. Newcastle disease virus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Newcastle Disease Virus with Improved Heat Resistance, and Newcastle Disease Virus Vaccine Comprising Same
#2RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
#3Larygotracheitis Virus (LT) Vector Vaccines for use with Avian Respiratory Pathogens
#4VACCINE AGAINST INFECTIOUS BRONCHITIS
#5RECOMBINANT NEWCASTLE DISEASE VIRUSES AND IMMUNOGENIC COMPOSITIONS FOR USE IN IMMUNIZING AGAINST SARS-COV-2 OMICRON VARIANT
#6MULTIVALENT KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS-LIKE PARTICLES AND USES THEREOF
#7USE OF CODON DEOPTIMISATION AND OPTIMISATION TO PRODUCE A LARYNGOTRACHEITIS VIRUS-ATTENUATED VACCINE
#8RECOMBINANT HERPESVIRUS OF TURKEY VECTORS EXPRESSING ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
#9RECOMBINANT HVT VECTORS EXPRESSING INFLUENZA HEMAGGLUTININ AND IMMUNOGENIC COMPOSITIONS, AND PRODUCTION AND USES THEREOF
#10CHIMERIC NEWCASTLE DISEASE VIRUS EXPRESSING APMV HN AND F PROTEINS
#11EXTENDED-RANGE SPRAY APPLICATOR
#12MULTIVALENT RECOMBINANT AVIAN HERPES VIRUSES AND VACCINES FOR IMMUNIZING AVIAN SPECIES
#13METHODS FOR IMMUNIZING PRE-IMMUNE SUBJECTS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV)
#14REDUCED FOAMING VACCINE COMPOSITIONS
#15RECOMBINANT HVT VECTORS EXPRESSING MULTIPLE ANTIGENS OF AVIAN PATHOGENS AND USES THEREOF
#16RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF
#17MULTIVALENT HVT VECTOR VACCINE
#18Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#19ENGINEERED NEWCASTLE DISEASE VIRUS VECTOR AND USES THEREOF
#20Vaccine delivery method
#21REDUCED FOAMING VACCINE COMPOSITIONS
#22Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)
#23Vaccine against infectious bronchitis
#24Multivalent Kaposi sarcoma-associated herpesvirus-like particles and uses thereof
#25Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#26Composite multi-epitope expression cassette, a recombinant virus composed thereof and application thereof
#27Method for rescuing and producing a virus in avian cells
#28USE OF BETA-GLUCAN EXTRACT IN IMMUNOPOTENTIATION OF AN AVIAN ANIMAL
#29Extended-range spray applicator
#30Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
#31Vaccine delivery method
#32Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof
#33Production of flu vaccine in
#34REDUCED FOAMING VACCINE COMPOSITIONS
#35Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#36Virus-like particle compositions and vaccines against epstein-barr virus infection and disease
#37Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)
#38Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof
#39Vaccine against infectious bronchitis
#40Methods of making solid vaccine compositions having reduced foaming
#41Reduced foaming vaccine compositions
#42INFECTIOUS BRONCHITIS VIRUS VACCINE USING NEWCASTLE DISEASE VIRAL VECTOR
#43Vaccine composition and preparation method and use thereof
#44Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#45Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#46Altered avian virus for in-ovo inoculation and methods of use thereof
#47Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#48Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof
#49DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES
#50Virus-like particle compositions and vaccines against Epstein-Barr virus infection and disease
#51In ovo delivery of probiotic cultures
#52Recombinant MDV1 and the uses thereof
#53Influenza H5 vaccines
#54HVT-vectored ND-IBD vaccine
#55Newcastle disease virus vectored avian vaccines
#56VACCINE DELIVERY METHOD
#57Oncolytic heterologous recombinant newcastle disease virus, preparation method and application thereof
#58In ovo delivery of probiotic cultures
#59Immunogenic composition
#60Infectious laryngotracheitis virus (ILTV) vaccine using recombinant newcastle disease virus vector
#61Chimeric viruses presenting non-native surface proteins and uses thereof
#62Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#63Traditional chinese medicine mulberry leaves polysaccharide and eucommia polysaccharide immunostimulant and application thereof
#64ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#65Method of making a virus using duck embryonic derived stem cell lines
#66Reduced foaming vaccine compositions
#67Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#68Recombinant Marek's disease viruses and uses thereof
#69Acceleration of vector virus induced immune response in avians
#70Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
#71Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
#72Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
#73Newcastle disease virus vectored herpesvirus vaccines
#74Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#75RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#76Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#77Recombinant nonpathogenic MDV vector providing multivalent immunity
#78Newcastle disease virus vectored avian vaccines
#79Immunostimulatory oligodeoxynucleotides
#80Recombinant vaccine against PRRS in a viral vector
#81Emulsion containing a non-live medicinal substance
#82Generation of duck cell lines
#83Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses
#84Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
#85Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
#86Newcastle disease virus and the use thereof as a vaccine
#87Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
#88RECOMBINANT MULTIMERIC INFLUENZA PROTEINS
#89Live vaccine for avian diseases
#90USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS
#91Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#92INACTIVATED POULTRY VACCINE
#93Chimeric viruses presenting non-native surface proteins and uses thereof
#94Sticky soft gel for treating poultry
#95Newcastle disease virus vectored herpesvirus vaccines
#96formulation
#97RECOMBINANT INACTIVATED VIRAL VECTOR VACCINE
#98COMPOSITION COMPRISING CHITOSAN FOR OCULAR ADMINISTRATION OF VACCINE(S) TO AVIANS
#99Recombinant NDV antigen and uses thereof
#100DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION
#101INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS
#102Virus-like particles as vaccines for paramyxovirus
#103Recombinant avian paramyxovirus vaccine and method for making and using thereof
#104Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof
#105Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
#106Newcastle disease virus vectored avian vaccines
#107NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#108Attenuated recombinant newcastle disease virus and vaccine containing the same
#109ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#110METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY
#111METHODS AND COMPOSITIONS FOR VACCINATION OF POULTRY
#112DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE PRODUCTION OF VIRAL VACCINES
#113Novel Vaccination Carrier
#114Preparation of vaccine master cell lines using recombinant plant suspension cultures
#115RECOMBINANT HERPESVIRUS USEFUL IN VACCINE PRODUCTION
#116Recombinant Newcastle Disease Virus Expressing H5 Hemagglutinin of Avian Influenza Virus
#117CpG DNA adjuvant in avian vaccines
#118VACCINE FOR IN OVO INOCULATION
#119Recombinant newcastle disease virus RNA expression systems and vaccines
#120Virus-like particles as vaccines for paramyxovirus
#121AVIAN VIRUS VACCINES AND USES THEREOF
#122Recombinant mononegaviral virus vectors
#123Methods for the propagation of modified influenza viruses in embryonated eggs
#124Virus-like particles as vaccines for paramyxovirus
#125Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#126Combination vaccine for poultry
#127DRY POWDER COMPOSITIONS AND SYSTEMS FOR POULTRY VACCINATION
#128Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents
#129Recombinant Herpesvirus Useful in Vaccine Production
#130Methods and compositions for vaccination of poultry
#131Methods and compositions for vaccination of poultry
#132Virus-like particles as vaccines for paramyxovirus
#133Preparation of vaccine master cell lines using recombinant plant suspension cultures
#134Stabilizers for veterinary vaccines
#135Vaccines
#136Recombinant avian herpesvirus useful in vaccine production
#137Coronavirus-like particles comprising functionally deleted genomes
#138Escape mutants of newcastle disease virus as marker vaccines
#139Methods and interferon deficient substrates for the propagation of viruses
#1403 (MDV-2), a viral vector against different avian pathogens: a new vaccination strategy in the poultry industry
#141Vaccine composition for preventing human infection of SARS coronavirus and alleviating infection symptoms